The Journal of infectious diseases

publication venue for

New perspectives on a subclinical form of visceral leishmaniasis. 1986
Effect of human exogenous leukocyte interferon in cytomegalovirus infections. 1976
Decoding Serum Metabolic Secrets of Nontuberculous Mycobacterial Pulmonary Disease. 2024
Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine. 2024
A bedaquiline, pyrazinamide, levofloxacin, linezolid, clofazimine second line regimen for tuberculosis displays similar early bactericidal activity as the standard rifampin based first line regimen. 2023
Development and Pilot of an Mpox Severity Scoring System (MPOX-SSS). 2023
Long COVID After Bamlanivimab Treatment.. 228. 2023
PFKFB3-meditated glycolysis via ROS-HIF1α axis contributes to inflammation and proliferation of Staphylococcus aureus in epithelial cells. 2023
Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology.. 227. 2023
Clinical Evaluation of Severe Acute Respiratory Syndrome Coronavirus 2 Rapid Antigen Tests During the Omicron Wave in South Africa.. 226. 2022
Elite neutralizers of human cytomegalovirus are characterized by high magnitude plasma IgG responses against multiple glycoprotein complexes. 2022
Frequent development of broadly neutralizing antibodies in early life in a large cohort of children living with HIV. 2021
Modeling the Impacts of Clinical Influenza Testing on Influenza Vaccine Effectiveness Estimates.. 224. 2021
Comparison of the Vaginal Microbiota in Postmenopausal Black and White Women.. 224. 2021
SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion.. 224. 2021
Human Immunodeficiency Virus-Associated Myocardial Diastolic Dysfunction and Soluble ST2 Concentration in Tanzanian Adults: A Cross-Sectional Study.. 223. 2021
Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities.. 222. 2020
Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment Program.. 222. 2020
Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City.. 222. 2020
Suboptimal Biological Sampling as a Probable Cause of False-Negative COVID-19 Diagnostic Test Results.. 222. 2020
Blood and Lymph Node Dissemination of Clonal Genome-Intact Human Immunodeficiency Virus 1 DNA Sequences During Suppressive Antiretroviral Therapy.. 222. 2020
Loss of Preexisting Immunological Memory Among Human Immunodeficiency Virus-Infected Women Despite Immune Reconstitution With Antiretroviral Therapy.. 222. 2020
Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease.. 221. 2020
Micronutrients, Immunological Parameters, and Dengue Virus Infection in Coastal Ecuador: A Nested Case-Control Study in an Infectious Disease Surveillance Program.. 221. 2020
Humoral Immune Correlates for Prevention of Postnatal Cytomegalovirus Acquisition.. 220. 2019
Altered Cervical Mucosal Gene Expression and Lower Interleukin 15 Levels in Women With Schistosoma haematobium Infection but Not in Women With Schistosoma mansoni Infection.. 219. 2019
Epidermal Growth Factor Receptor-Responsive Indoleamine 2,3-Dioxygenase Confers Immune Homeostasis During Shigella flexneri Infection.. 219. 2019
The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies.. 218. 2018
Impact of Zostavax Vaccination on T-Cell Accumulation and Cutaneous Gene Expression in the Skin of Older Humans After Varicella Zoster Virus Antigen-Specific Challenge.. 218. 2018
Normalization of Soluble CD163 Levels After Institution of Antiretroviral Therapy During Acute HIV Infection Tracks with Fewer Neurological Abnormalities.. 218. 2018
Challenges for the MD Physician-Scientist Upon Entering the Lab: From the Grand to the Practical.. 218. 2018
Inducible Costimulator Contributes to Methicillin-Resistant Staphylococcus aureus Pneumonia.. 218. 2018
Differences in the Immune Microenvironment of Anal Cancer Precursors by HIV Status and Association With Ablation Outcomes.. 217. 2018
Genetic Variation at IFNL4 Influences Extrahepatic Interferon-Stimulated Gene Expression in Chronic HCV Patients.. 217. 2018
Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants.. 216. 2017
Future Research Priorities in Fungal Resistance.. 216. 2017
Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.. 215. 2017
Association Between Frailty and Components of the Frailty Phenotype With Modifiable Risk Factors and Antiretroviral Therapy.. 215. 2017
Plasma Cytokines and Chemokines in Zambian Children With Measles: Innate Responses and Association With HIV-1 Coinfection and In-Hospital Mortality.. 215. 2017
Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305).. 215. 2017
Chronic Hepatitis C Virus Infection and the Proinflammatory Effects of Injection Drug Use.. 214. 2016
Fibrosis Progression in Patients With Chronic Hepatitis C Virus Infection.. 214. 2016
Immunologic Markers of Protection in Leishmania (Viannia) braziliensis Infection: A 5-Year Cohort Study.. 214. 2016
Role of Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Regulating Neutrophil Antifungal Activity and the Oxidative Burst During Respiratory Fungal Challenge.. 213. 2016
Persistent HIV Type 1 Seronegative Status Is Associated With Lower CD8+ T-Cell Activation.. 213. 2015
Loss of Microbiota-Mediated Colonization Resistance to Clostridium difficile Infection With Oral Vancomycin Compared With Metronidazole.. 212. 2015
Transcriptional changes that characterize the immune reactions of leprosy.. 211. 2014
Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults Previously Vaccinated With Pneumococcal Polysaccharide Vaccine.. 212. 2014
Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses.. 211. 2014
Dectin-1-dependent LC3 recruitment to phagosomes enhances fungicidal activity in macrophages.. 210. 2014
Carbapenem-resistant Klebsiella pneumoniae exhibit variability in capsular polysaccharide and capsule associated virulence traits.. 210. 2014
Differences in antibody responses between trivalent inactivated influenza vaccine and live attenuated influenza vaccine correlate with the kinetics and magnitude of interferon signaling in children.. 210. 2014
Clinical and epidemiologic characteristics of respiratory syncytial virus infection among children aged <5 years, Jingzhou City, China, 2011.. 208 Suppl 3. 2013
Molecular characterization of an invasive phenotype of group A Streptococcus arising during human infection using whole genome sequencing of multiple isolates from the same patient.. 209. 2013
Identification of collagenase as a critical virulence factor for invasiveness and transmission of pathogenic Leptospira species.. 209. 2013
Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b study.. 209. 2013
Inflammatory monocytes mediate early and organ-specific innate defense during systemic candidiasis.. 209. 2013
Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.. 208. 2013
Alternative mutational pathways to intermediate resistance to vancomycin in methicillin-resistant Staphylococcus aureus.. 208. 2013
Abrupt emergence of a single dominant multidrug-resistant strain of Escherichia coli.. 207. 2013
Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202.. 207. 2012
HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status.. 206. 2012
Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202.. 207. 2012
Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremia.. 206. 2012
A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256.. 206. 2012
Metabolomic analysis of patient plasma yields evidence of plant-like α-linolenic acid metabolism in Plasmodium falciparum.. 206. 2012
CAPRISA 004 tenofovir microbicide trial: no impact of tenofovir gel on the HIV transmission bottleneck.. 206. 2012
Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.. 205. 2012
Staphylococcus epidermidis colonization is highly clonal across US cardiac centers.. 205. 2012
CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studies.. 205. 2012
Polymorphisms in regulator of protease B (RopB) alter disease phenotype and strain virulence of serotype M3 group A Streptococcus.. 205. 2012
Natality decline and miscarriages associated with the 1918 influenza pandemic: the Scandinavian and United States experiences.. 204. 2011
Maternal cytomegalovirus-specific immune responses and symptomatic postnatal cytomegalovirus transmission in very low-birth-weight preterm infants.. 204. 2011
Nutritional status and mortality among HIV-infected patients receiving antiretroviral therapy in Tanzania.. 204. 2011
Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202.. 203. 2011
Defense from the Group A Streptococcus by active and passive vaccination with the streptococcal hemoprotein receptor.. 203. 2011
Pilot study of oral valganciclovir therapy in patients with classic Kaposi sarcoma.. 203. 2011
Factors associated with viral rebound in HIV-1-infected individuals enrolled in a therapeutic HIV-1 gag vaccine trial.. 203. 2011
An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: results from a randomized placebo-controlled trial (the Step study).. 203. 2011
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men.. 202. 2010
Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study.. 202. 2010
Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor.. 202. 2010
Effectiveness of varicella vaccine in children infected with HIV.. 201. 2010
Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure.. 201. 2010
Preservation of memory CD4(+) T lymphocytes in breast milk of lactating rhesus monkeys during acute simian immunodeficiency virus infection.. 201. 2010
Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211.. 200. 2009
Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania.. 200. 2009
CYP2B6 variants and plasma efavirenz concentrations during antiretroviral therapy in Port-au-Prince, Haiti.. 200. 2009
Essential role for neutrophils but not alveolar macrophages at early time points following Aspergillus fumigatus infection.. 200. 2009
Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects.. 200. 2009
Interleukin-10 promoter polymorphisms influence HIV-1 susceptibility and primary HIV-1 pathogenesis.. 200. 2009
Methamphetamine enhances histoplasmosis by immunosuppression of the host.. 200. 2009
Human TRIM5alpha expression levels and reduced susceptibility to HIV-1 infection.. 199. 2009
Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection.. 199. 2009
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes.. 199. 2009
The impact of steroids given with macrolide therapy on experimental Mycoplasma pneumoniae respiratory infection.. 198. 2008
Relationship between levels of inflammatory cytokines in the genital tract and CD4+ cell counts in women with acute HIV-1 infection.. 198. 2008
Vaccination with clumping factor A and fibronectin binding protein A to prevent Staphylococcus aureus infection of an aortic patch in mice.. 198. 2008
Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure.. 198. 2008
Efavirenz-based regimens in treatment-naive patients with a range of pretreatment HIV-1 RNA levels and CD4 cell counts.. 197. 2008
Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects.. 197. 2008
Simian immunodeficiency virus-induced intestinal cell apoptosis is the underlying mechanism of the regenerative enteropathy of early infection.. 197. 2008
Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2.. 197. 2008
The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates.. 197. 2008
Clinical measles after measles virus challenge in simian immunodeficiency virus-infected measles virus-vaccinated rhesus monkeys.. 196. 2007
alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism(s).. 196. 2007
Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211.. 196. 2007
Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.. 195. 2007
Isolated hepatitis B core antibody is associated with HIV and ongoing but not resolved hepatitis C virus infection in a cohort of US women.. 195. 2007
Antiretroviral therapy for HIV-1-infected children in Haiti.. 195. 2007
Individuals with pulmonary tuberculosis have lower levels of circulating CD1d-restricted NKT cells.. 195. 2007
Plasma HIV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens: ACTG A5166s.. 195. 2007
Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy.. 195. 2006
Influence of helminth infections on the clinical course of and immune response to Leishmania braziliensis cutaneous leishmaniasis.. 195. 2006
Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen.. 194. 2006
A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086.. 194. 2006
Fabry disease in mice protects against lethal disease caused by Shiga toxin-expressing enterohemorrhagic Escherichia coli.. 194. 2006
Triazole-polyene antagonism in experimental invasive pulmonary aspergillosis: in vitro and in vivo correlation.. 194. 2006
Highly resistant Salmonella Newport-MDRAmpC transmitted through the domestic US food supply: a FoodNet case-control study of sporadic Salmonella Newport infections, 2002-2003.. 194. 2006
The survival benefits of AIDS treatment in the United States.. 194. 2006
The role of Staphylococcus aureus adhesins in the pathogenesis of ventricular assist device-related infections.. 193. 2006
Disproportionately high semen shedding of HIV is associated with compartmentalized cytomegalovirus reactivation.. 193. 2005
PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial.. 193. 2005
Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus.. 192. 2005
Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection.. 192. 2005
Association between genital tract cytomegalovirus infection and bacterial vaginosis.. 192. 2005
Higher frequency of HIV-1-specific T cell immune responses in African American children vertically infected with HIV-1.. 192. 2005
Genome sequence of a serotype M28 strain of group a streptococcus: potential new insights into puerperal sepsis and bacterial disease specificity.. 192. 2005
Nutritional status and serum cytokine profiles in children, adolescents, and young adults with Schistosoma japonicum-associated hepatic fibrosis, in Leyte, Philippines.. 192. 2005
Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C.. 192. 2005
Neutralization of endotoxin by a phospholipid emulsion in healthy volunteers.. 191. 2005
In vivo transcriptome of Plasmodium falciparum reveals overexpression of transcripts that encode surface proteins.. 191. 2005
Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women.. 191. 2005
Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection.. 191. 2005
Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations.. 191. 2005
Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy.. 190. 2004
Limited contribution of humoral immunity to the clearance of measles viremia in rhesus monkeys.. 190. 2004
Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjects.. 190. 2004
Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection.. 189. 2004
Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359.. 189. 2004
Short-term safety and antiretroviral activity of T-1249, a second-generation fusion inhibitor of HIV.. 189. 2004
Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trial.. 189. 2004
Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection.. 188. 2003
Changes in the levels of chemokines and cytokines in the placentas of women with Plasmodium falciparum malaria.. 188. 2003
Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.. 188. 2003
Determinants of response to interleukin-10 receptor blockade immunotherapy in experimental visceral leishmaniasis.. 188. 2003
Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.. 188. 2003
Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin.. 187. 2003
Detection of Ureaplasma urealyticum in second-trimester amniotic fluid by polymerase chain reaction correlates with subsequent preterm labor and delivery.. 187. 2003
Induction of apoptosis of human brain microvascular endothelial cells by shiga toxin 1.. 187. 2002
Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil.. 186. 2002
Molecular basis for up-regulation by inflammatory cytokines of Shiga toxin 1 cytotoxicity and globotriaosylceramide expression.. 186. 2002
Diversity of penicillin-nonsusceptible Streptococcus pneumoniae circulating in Iceland after the introduction of penicillin-resistant clone Spain(6B)-2.. 186. 2002
Influence of filgrastim (granulocyte colony-stimulating factor) on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitis.. 186. 2002
Durability of response to treatment among antiretroviral-experienced subjects: 48-week results from AIDS Clinical Trials Group Protocol 359.. 186. 2002
The pharmacokinetics of amprenavir, zidovudine, and lamivudine in the genital tracts of men infected with human immunodeficiency virus type 1 (AIDS clinical trials group study 850).. 186. 2002
Cryptosporidiosis stimulates an inflammatory intestinal response in malnourished Haitian children.. 186. 2002
Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients.. 185. 2002
Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure.. 185. 2002
Dexamethasone inhibits CD4 T cell deletion mediated by macrophages from human immunodeficiency virus-infected persons.. 184. 2001
Multilocus sequence typing of Streptococcus pneumoniae clones with unusual drug resistance patterns: genetic backgrounds and relatedness to other epidemic clones.. 184. 2001
Osteonecrosis in patients infected with human immunodeficiency virus: a case-control study.. 184. 2001
Patterns of plasma human immunodeficiency virus type 1 RNA response to antiretroviral therapy.. 183. 2001
Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years.. 183. 2001
Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373.. 183. 2001
Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction.. 183. 2001
Antibodies to streptococcal surface enolase react with human alpha-enolase: implications in poststreptococcal sequelae.. 182. 2000
Interleukin-12 regulates the response to chemotherapy in experimental visceral Leishmaniasis.. 182. 2000
Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group Study 359.. 182. 2000
Carriage of internationally spread clones of Streptococcus pneumoniae with unusual drug resistance patterns in children attending day care centers in Lisbon, Portugal.. 182. 2000
Effect of transfusional iron overload on immune response.. 182 Suppl 1. 2000
Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption.. 182. 2000
Localization of endotoxin in the rat intestinal epithelium.. 182. 2000
The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection.. 182. 2000
Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system.. 182. 2000
The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in children.. 182. 2000
The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850).. 181. 2000
The relationship between T cell proliferative responses and plasma viremia during treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy.. 181. 2000
Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy.. 181. 2000
Molecular typing of Streptococcus pneumoniae in northeastern Romania: unique clones of S. pneumoniae isolated from children hospitalized for infections and from healthy and human immunodeficiency virus-infected children in the community.. 181. 2000
Visceral leishmanicidal activity of hexadecylphosphocholine (miltefosine) in mice deficient in T cells and activated macrophage microbicidal mechanisms.. 181. 2000
Polyspecific self-reactive antibodies in individuals infected with human immunodeficiency virus facilitate T cell deletion and inhibit costimulatory accessory cell function.. 180. 1999
Effect of chemokine receptor mutations on heterosexual human immunodeficiency virus transmission.. 180. 1999
Heterogeneity of viral IL-6 expression in HHV-8-associated diseases.. 180. 1999
Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment.. 180. 1999
Relationship between Ureaplasma urealyticum vaginal colonization and polymorphism in the interleukin-1 receptor antagonist gene.. 180. 1999
Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in children.. 180. 1999
Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study Team.. 179. 1999
Antiviral activity of the human immunodeficiency virus type 1-specific nonnucleoside reverse transcriptase inhibitor HBY 097 alone and in combination with zidovudine in a phase II study. HBY 097/2001 Study Group.. 179. 1999
The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses.. 179. 1999
Longitudinal and cross-sectional analysis of cytotoxic T lymphocyte responses and their relationship to vertical human immunodeficiency virus transmission. ARIEL Project Investigators.. 178. 1998
Therapeutic effect of interferon-gamma gene transfer in experimental visceral leishmaniasis.. 178. 1998
Lymphocyte-reactive autoantibodies in human immunodeficiency virus type 1-infected persons facilitate the deletion of CD8 T cells by macrophages.. 178. 1998
Molecular epidemiology of methicillin-resistant Staphylococcus aureus in 12 New York hospitals. MRSA Collaborative Study Group.. 178. 1998
Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study.. 177. 1998
Capsular transformation of a multidrug-resistant Streptococcus pneumoniae in vivo.. 177. 1998
Humoral immune response to conserved epitopes of Chlamydia trachomatis and human 60-kDa heat-shock protein in women with pelvic inflammatory disease.. 177. 1998
Splenic cytokine responses in Indian kala-azar before and after treatment.. 177. 1998
Antiserum against Escherichia coli J5 contains antibodies reactive with outer membrane proteins of heterologous gram-negative bacteria.. 176. 1997
Relationship of tissue and cellular interleukin-1 and lipopolysaccharide after endotoxemia and bacteremia.. 176. 1997
Response to interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis.. 176. 1997
Pretreatment with a 55-kDa tumor necrosis factor receptor-immunoglobulin fusion protein attenuates activation of coagulation, but not of fibrinolysis, during lethal bacteremia in baboons.. 176. 1997
Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis.. 175. 1997
Ultrastructural and antigenic characterization of a granulocytic ehrlichiosis agent directly isolated and stably cultivated from a patient in New York state.. 175. 1997
The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study.. 174. 1996
Comparable growth of virulent and avirulent Mycobacterium tuberculosis in human macrophages in vitro.. 174. 1996
Interleukin-12 restores interferon-gamma production and cytotoxic responses in visceral leishmaniasis.. 173. 1996
Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study.. 173. 1996
Models of relapse of experimental visceral leishmaniasis.. 173. 1996
Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex.. 173. 1996
Effect of treatment with interferon-gamma alone in visceral leishmaniasis.. 172. 1995
Interleukin-1 contributes to increased concentrations of soluble tumor necrosis factor receptor type I in sepsis.. 172. 1995
Empirically treated Pneumocystis carinii pneumonia in Los Angeles, Chicago, and Miami: 1987-1990.. 172. 1995
Chlamydia trachomatis detected by polymerase chain reaction in cervices of culture-negative women correlates with adverse in vitro fertilization outcome.. 171. 1995
Antimicrobial response of a T cell-deficient host to cytokine therapy: effect of interferon-gamma in experimental visceral leishmaniasis in nude mice.. 171. 1995
Immunochemotherapy for a systemic intracellular infection: accelerated response using interferon-gamma in visceral leishmaniasis.. 171. 1995
Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: evidence suggesting capsular transformation of the resistant strain in vivo.. 171. 1995
Stavudine in patients with AIDS and AIDS-related complex: AIDS clinical trials group 089.. 171 Suppl 2. 1995
Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamma.. 170. 1994
Recombinant human granulocyte-macrophage colony-stimulating factor reverses neutropenia and reduces secondary infections in visceral leishmaniasis.. 170. 1994
Heat-shock proteins expressed on the surface of human T cell leukemia virus type I-infected cell lines induce autoantibodies in rabbits.. 169. 1994
High-molecular-weight surface-exposed proteins of Haemophilus influenzae mediate binding to macrophages.. 169. 1994
Cellular distribution of endotoxin after injection of chemically purified lipopolysaccharide differs from that after injection of live bacteria.. 169. 1994
Circulating Borrelia burgdorferi in patients with acute Lyme disease: results of blood cultures and serum DNA analysis.. 168. 1993
Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine. Zidovudine Epidemiology Study Group.. 168. 1993
Cytokine gene activation and modified responsiveness to interleukin-2 in the blood of tuberculosis patients.. 168. 1993
Isolation of Mycobacterium avium complex from bone marrow aspirates of AIDS patients in Brazil.. 168. 1993
A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS.. 168. 1993
DNA amplification in experimental pneumocystosis: characterization of serum Pneumocystis carinii DNA and potential P. carinii carrier states.. 168. 1993
Recombinant vaccinia virus expressing the PR/8 influenza hemagglutinin gene overcomes the impaired immune response and increased susceptibility of old mice to influenza infection.. 168. 1993
Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s.. 168. 1993
Cell-mediated immune response to the recombinant 57-kDa heat-shock protein of Chlamydia trachomatis in women with salpingitis.. 167. 1993
Response to treatment for an intracellular infection in a T cell-deficient host: toxoplasmosis in nude mice.. 167. 1993
Human anti-endotoxin antibody HA-1A mediates complement-dependent binding of Escherichia coli J5 lipopolysaccharide to complement receptor type 1 of human erythrocytes and neutrophils.. 167. 1993
Triggering of pneumococcal autolysis by lysozyme.. 167. 1993
Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus.. 167. 1993
Efficacy of low doses of the polyethylene glycol derivative of interleukin-2 in modulating the immune response of patients with human immunodeficiency virus type 1 infection.. 167. 1993
Sinusitis and atopy in human immunodeficiency virus infection.. 167. 1993
Type b capsule inhibits ingestion of Haemophilus influenzae by murine macrophages: studies with isogenic encapsulated and unencapsulated strains.. 166. 1992
Diminished in vitro production of interleukin-1 and tumor necrosis factor-alpha during acute visceral leishmaniasis and recovery after therapy.. 165. 1992
The role of complement and murine monoclonal antibodies in binding and ingestion of Haemophilus influenzae type b by murine macrophages.. 165 Suppl 1. 1992
Tolerance to endotoxin prevents mortality in infected thermal injury: association with attenuated cytokine responses.. 165. 1992
Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi.. 165. 1992
L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes.. 165. 1992
In vivo stability of heterogeneous expression classes in clinical isolates of methicillin-resistant staphylococci.. 164. 1991
Effect of Candida albicans plus histamine on prostaglandin E2 production by peripheral blood mononuclear cells from healthy women and women with recurrent candidal vaginitis.. 164. 1991
Evidence for clonal spread of a single strain of beta-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states.. 163. 1991
Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary.. 163. 1991
Response to chemotherapy in experimental visceral leishmaniasis: T cell-dependent but interferon-gamma- and interleukin-2-independent.. 163. 1991
Effect of continuous administration of interferon-gamma in experimental visceral leishmaniasis.. 161. 1990
Tropical pulmonary eosinophilia: analysis of antifilarial antibody localized to the lung.. 160. 1989
Interferon-gamma and Mycobacterium avium-intracellulare infection.. 159. 1989
Penicillin-binding protein families: evidence for the clonal nature of penicillin resistance in clinical isolates of pneumococci.. 159. 1989
In vivo killing of intracellular visceral Leishmania donovani by a macrophage-targeted hydrogen peroxide-generating system.. 158. 1988
Immunization of healthy adults with live attenuated varicella vaccine.. 158. 1988
Penicillin resistance and defective lysis in clinical isolates of pneumococci: evidence for two kinds of antibiotic pressure operating in the clinical environment.. 157. 1988
Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony.. 157. 1988
Effect of ethanol on functions required for the delivery of neutrophils to sites of inflammation.. 157. 1988
The contribution of pneumococcal cell wall to the pathogenesis of experimental otitis media.. 157. 1988
Complement-mediated early clearance of Haemophilus influenzae type b from blood is independent of serum lytic activity.. 157. 1988
Malnutrition as a risk factor for severe visceral leishmaniasis.. 156. 1987
Patterns of antibodies to human immunodeficiency virus proteins in different subclasses of IgG.. 156. 1987
Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis.. 156. 1987
Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis.. 155. 1987
Asymptomatic Chlamydia trachomatis infections among sexually active men.. 154. 1986
A prospective study of visceral leishmaniasis in an endemic area of Brazil.. 154. 1986
2'-Fluoro-5-iodoarabinosylcytosine, a new potent antiviral agent: efficacy in immunosuppressed individuals with herpes zoster.. 154. 1986
A model for predicting nephrotoxicity in patients treated with aminoglycosides.. 153. 1986
Defects in vitamin K-dependent carboxylation associated with moxalactam treatment.. 153. 1986
Role of circulating immune complexes in human secondary syphilis.. 153. 1986
Enzyme immunoassay detection of immunoglobulin M and G antibodies to Cryptosporidium in immunocompetent and immunocompromised persons.. 153. 1986
Typhoid fever: successful therapy with cefoperazone.. 153. 1986
Alterations in penicillin-binding proteins of clinical and laboratory isolates of pathogenic Streptococcus pneumoniae with low levels of penicillin resistance.. 153. 1986
Penicillin tolerance in multiply drug-resistant natural isolates of Streptococcus pneumoniae.. 152. 1985
The induction of meningeal inflammation by components of the pneumococcal cell wall.. 151. 1985
The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis.. 151. 1985
Epidemiology of endemic Pseudomonas aeruginosa: why infection control efforts have failed.. 150. 1984
Three-step stool examination for cryptosporidiosis in 10 homosexual men with protracted watery diarrhea.. 147. 1983
Gentamicin-resistant staphylococci as hospital flora: epidemiology and resistance plasmids.. 145. 1982
Immunization against influenza in children with cancer: results of a three-dose trial.. 145. 1982
Identity and interspecific transfer of gentamicin-resistance plasmids in Staphylococcus aureus and Staphylococcus epidermidis.. 141. 1980
Endemic aminoglycoside resistance in gram-negative bacilli: epidemiology and mechanisms.. 141. 1980
Relative efficacy of clindamycin, erythromycin, and penicillin in treatment of Treponema pallidum in skin syphilomas of rabbits.. 134. 1976
Gentamicin levels in the human biliary tract.. 127. 1973
Interbacterial transfer of R factor in the human intestine: in-vivo acquisition of R-factor-mediated kanamycin resistance by a multiresistant strain of Shigella sonnei.. 126. 1972
Another Call for Widespread Human Papillomavirus Vaccination.. 222. 2020
Time to refocus on HSV interventions for HIV prevention?. 204. 2011
Recombinant gp120, antibodies to the V3 region of gp120, and neural progenitor cells.. 191. 2005
Repetitive mucosal exposure to human herpesvirus-8 and protection against its penile-vaginal transmission.. 188. 2003
Clinical trials of HIVIG.. 178. 1998
Neutralization assays using the BZ167 strain of human immunodeficiency virus type 1.. 176. 1997
Human immunodeficiency virus infection and bacteremic meningococcal pneumonia.. 163. 1991
Fungal cholecystitis and AIDS.. 161. 1990
Inhibition of the Salmonella typhi oral vaccine strain, Ty21a, by mefloquine and chloroquine. 1992
Broadly Neutralizing Antihuman Immunodeficiency Virus Antibodies in Infants: Promising New Tools for Prevention of Mother-to-Child Transmission?. 222. 2020
T cell immunity in acute HIV-1 infection. 2010
The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis. 1993

VIVO Weill Cornell Medical College

The Journal of infectious diseases Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)